NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1265559199 MD
Verify on CMS → Ilmana Fulger, MD
Hematology & Oncology Physician in Bronx, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 176 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
0%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$3.3K
110 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Ilmana Fulger, MD filed 1,437 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Bronx, New York, prescribing 0% generic.
- 1K
- Part D claims, 2024
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥80th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ilmana Fulger, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1265559199), first enumerated 03/24/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,437 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$3.3K in reported industry payments (110 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Ilmana Fulger, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1265559199 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1265559199
- ENUM-MID 2007
- TAX-MID 12K Hematology &
- RX-MID 1,437
- BOOK-LIGHT 999 in New York
- PHOTO-ENUM Michael Bergeron, M.D. · 2007
Ilmana Fulger, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,437 ≥ 80th percentile 80% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Ilmana Fulger, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ilmana Fulger, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,437 62% vs specialty avg
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1265559199 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/24/2007 |
Hospital and facility affiliations
Facilities where Ilmana Fulger, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sbh Physicians PC
Bronx, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ilmana Fulger, MD. Source: openpaymentsdata.cms.gov.
Total received
$3.3K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Ilmana Fulger, MD. To verify Ilmana Fulger, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Ilmana Fulger, MD - brand share 51.0%
Hematology & Oncology Physician average
51% brand-name claims vs 0% generic, on 1,437 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,437
Total Claims
$5.5M
Total Drug Cost
176
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,102
- Total Day Supply
- 57,698
- Brand vs Generic
- 51% brand / 0% generic
- Brand Drug Cost
- $4.9M
- Opioid Claims
- 47 (3.3% rate)
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 2.16
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 28, 65-74: 68, 75-84: 60, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ilmana Fulger, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Xgeva
Xgeva
162 claims
- Letrozole
Letrozole
84 claims
- Keytruda
Keytruda
75 claims
- Warfarin Sodium
Warfarin Sodium
72 claims
- Lupron Depot 54
Lupron Depot
54 claims
- Prolia 50
Prolia
50 claims
- Nubeqa 44
Nubeqa
44 claims
- Darzalex Faspro 41
Darzalex Faspro
41 claims
| Drug | Claims |
|---|---|
| Xgeva Denosumab | 162 |
| Letrozole | 84 |
| Keytruda Pembrolizumab | 75 |
| Warfarin Sodium | 72 |
| Lupron Depot Leuprolide Acetate | 54 |
| Prolia Denosumab | 50 |
| Nubeqa Darolutamide | 44 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 41 |
| Hydroxyurea | 37 |
| Orgovyx Relugolix | 37 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Ilmana Fulger, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Ilmana Fulger, MD's 1,437 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Fulger, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Fulger.
One of 999 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ilmana Fulger, MD's specialty? ▼
Ilmana Fulger, MD specializes in Hematology & Oncology Physician and practices in Bronx, New York. Credentials: MD.
How much does Ilmana Fulger, MD prescribe under Medicare Part D? ▼
In 2024, Ilmana Fulger, MD wrote 1,437 Medicare Part D claims totaling $5.5M in drug costs for 176 beneficiaries.
Where is Ilmana Fulger, MD located? ▼
Ilmana Fulger, MD is located at 4487 3RD AVE, Bronx, NY, 10457. Phone: (718) 960-6377.
What is Ilmana Fulger, MD's NPI number? ▼
Ilmana Fulger, MD's National Provider Identifier (NPI) is 1265559199, issued on 03/24/2007.
Does Ilmana Fulger, MD prescribe more brand-name or generic drugs? ▼
Ilmana Fulger, MD's prescribing is 51% brand-name and 0% generic drugs by claim count, with $4.9M in brand drug costs.
Does Ilmana Fulger, MD prescribe opioids? ▼
Yes, Ilmana Fulger, MD had 47 opioid claims in 2024 with an opioid prescribing rate of 3.3%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Ilmana Fulger, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Ilmana Fulger, MD's most frequently prescribed drugs include Xgeva, Letrozole, Keytruda. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ilmana Fulger, MD accept Medicare? ▼
Ilmana Fulger, MD appears in CMS Medicare data with 1,437 Part D claims and 176 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ilmana Fulger, MD's credentials? ▼
Ilmana Fulger, MD's NPI is 1265559199 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.